Sarcopenia in older adults is characterized by the core features of skeletal muscle mass loss, decreased muscle strength, and decline in physical function. It severely impacts activities of daily living and increases the risk of falls, disability, and mortality. With the accelerating aging of the global population, the clinical management of sarcopenia has become increasingly urgent. Traditional intervention methods are limited by issues such as uneven distribution of resources, low adherence, and insufficient personalization, making it difficult to meet the needs of large-scale elderly populations. In recent years, digital technologies have demonstrated significant potential in sarcopenia management due to their precision, convenience, and interactive advantages, becoming a focus of research. To conduct a scoping review of studies on the application of digital technologies in the management of sarcopenia among older adults in Asian regions. Clinical research on digital technologies in sarcopenia interventions for older adults included mobile applications, virtual reality, mixed reality, and artificial intelligence-assisted human pose estimation techniques. The studies were conducted in China, Thailand, and South Korea, with participants being sarcopenia patients aged 60-80 years from community or rural healthcare settings. The intervention duration ranged from 4 to 12 weeks. Applications of digital technologies in this field included recording patient treatment data, developing personalized treatment plans, monitoring treatment processes and outcomes, and evaluating therapeutic effects. In existing studies conducted in Asian regions, compared with traditional therapies, the application and implementation of digital technologies in sarcopenia interventions for older adults can improve patients' muscle mass, muscle strength, and physical function. Some studies suggest that digital technologies also provide certain benefits for patients' quality of life and activities of daily living. However, the clinical application of digital technologies in sarcopenia interventions in this region remains exploratory. Future research requires longer-term, larger-scale clinical trials to further validate their effectiveness and generalizability.

老年人肌少症以骨骼肌量流失、肌肉力量下降及身体功能衰退为核心特征，严重影响日常活动能力，增加跌倒、残疾及死亡风险。随着全球人口老龄化加剧，其临床管理需求日益迫切。传统干预手段受限于资源分布不均、依从性低及个性化不足等问题，难以满足大规模老年群体需求。近年来，数字技术凭借精准化、便捷化及交互式优势，在肌少症管理中展现出显著潜力，成为研究热点。本研究对数字技术在亚洲地区老年人肌少症干预中的应用进行范围综述。数字技术在老年人肌少症干预中的临床研究包括移动应用程序、虚拟现实、混合现实及人工智能辅助人体姿态估计技术。研究覆盖中国、泰国、韩国，干预对象为60~80岁社区或农村卫生保健机构肌少症患者，干预周期为4~12周。数字技术在该领域干预中的应用包括记录患者治疗数据、制订个性化治疗方案、监测治疗过程与结果和评估治疗效果。在已开展的亚洲地区研究中，与传统疗法相比，数字技术在老年人肌少症干预中的应用与实施，能够改善患者的肌肉质量、肌肉力量和身体功能，部分研究表明数字技术对患者生活质量和日常生活活动能力有一定的帮助。然而，目前该地区数字技术在肌少症干预中的临床应用尚处于探索阶段，未来需要开展更长周期、更大样本量的临床试验，以进一步验证其有效性与普适性。